GenSight KOL Event June

New York, June 12, 2018
Register for Event / Log Back in

Additional menu options can be found in the menu bar on the left or at the top.

GenSight Biologics [SIGHT:PA] €44 MM MCap
In­no­va­tive gene ther­a­pies for reti­nal and CNS de­gen­er­a­tive patholo­gies and mi­to­chon­drial dis­ease. Lead prod­uct, GS010, is in Ph 3 for the treat­ment of Le­ber Hered­i­tary Op­tic Neu­ro­pa­thy (LHON). RE­V­ERSE... [more in­for­ma­tion]